HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

Drug price hikes without new evidence upped spending by $1.2B

The Institute for Clinical and Economic Review (ICER) published its second-ever report on Unsupported Price Increases (UPI) last week, compiled from data supplied by SSR Health, which is part of the investment research firm SSR. While the medical pricing watchdog found that overall spending was […]

more info 01/22/2021View Related Articles
Bookmark and Share

Value-Based Purchasing Rule For Medicaid Rx Drugs

Writing in Health Affairs, outgoing CMS Administrator Seema Verma touts how the Trump Administration helped paved the way for more outcomes-based contracts on prescription drugs by clarifying that these contracts won’t run afoul of the Medicaid “best price” provision -- provided that Medicaid […]

more info 01/22/2021View Related Articles
Bookmark and Share

Democrats Have Their Best Shot Yet at Letting Medicare Negotiate Drug Prices

Democrats have their best shot in more than a decade to deliver on one of the party’s central health care promises: allowing Medicare to directly negotiate prescription drug prices. But it’s far from guaranteed that they can deliver. Read more here. (Source: Nicholas Flokko; STAT; 1/21/21) […]

more info 01/21/2021View Related Articles
Bookmark and Share

How a Former Health Care Executive Became a Health Care Whistleblower

Former health care executive Wendell Potter spent part of 2020 publishing high-profile apologies for the work he used to do — the lies he said he told the American people for his old employers. These days, he said, he’s also trying to debunk myths he once sold. “What I used to do for a living was […]

more info 01/19/2021View Related Articles
Bookmark and Share

(Podcast) Bridge the City: Opportunity Costs of Healthcare in the US

Researchers David Vanness and James Lomas joined the Bridge the City podcast to explain the conclusions of their new paper, "A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States." They describe how pharmaceutical products whose prices do not represent good value […]

more info 01/19/2021View Related Articles
Bookmark and Share

[Podcast] How Doctors Can Be a Part of the Solution

In the final episode of our podcast's inaugural season, neurologist Jason Crowell and ICER's President Steve Pearson discuss what physicians can do in their hospitals and communities to advocate for fair drug prices, and they explore what questions doctors should ask patients to assess for financial […]

more info 01/19/2021View Related Articles
Bookmark and Share

State Level Action in Response to ICER’s Unsupported Price Increase Report

In ICER’s latest report on Unsupported Price Increases (UPI), we determined that 7 of the 10 costliest US drug-price hikes in 2019 lacked new evidence of a previously unknown clinical benefit. Even after accounting for rebates, the unsupported price increases on just these 7 drugs cost Americans an […]

more info 01/18/2021View Related Articles
Bookmark and Share

New Data Show Retail Medicine Prices Fell in 2019

In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & Medicaid Services (CMS) published recently in Health Affairs. While retail prescription medicine spending grew 5.7% that same year, this […]

more info 01/14/2021View Related Articles
Bookmark and Share

Implications of Price Transparency for Providers and Patients as New Rules Go into Effect

A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common […]

more info 01/13/2021View Related Articles
Bookmark and Share

Specialty Generics Face Perverse Incentives In Medicare Part D

Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of rebates drugmakers are willing to offer to a pharmacy benefit manager (PBM) to secure preferred placement on the formulary. Originator firms can outmaneuver specialty […]

more info 01/12/2021View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Sr. Manager of HEOR Analytics
  • Manager of Commercial Analytics
  • Assistant Director - Oncology Strategy & Communications (Remote)
  • Senior Director - Evidence Generation & Value Communications (Remote)
  • Medical Writer
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists